WebMar 31, 2024 · Novacyt SA NYZ Ownership Morningstar Rating Rating as of Mar 6, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability Trailing Returns … WebOct 15, 2024 · Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the acquisition of the entire share capital of IT-IS International Ltd (IT-IS), a...
Novacyt Insider Trading & Ownership Structure - Simply Wall St
WebFeb 24, 2016 · The Novacyt Group is a leader in the field of cellular diagnostics with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform ... WebMar 10, 2024 · How much insider buying is happening at Novacyt? Insiders have purchased a total of 56,068 NCYT shares in the last 24 months for a total of £121,409.48 bought. This page (LON:NCYT) was last updated on 3/11/2024 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free. Sign up for MarketBeat All Access to gain access to … convert string to object id
Novacyt : 2024 half year revenues MarketScreener
WebNovacyt S.A. ("Novacyt", the "Company" or the "Group"): DHSC Claim Update – Trial Date Listed. PARIS & EASTLEIGH, England, January 30, 2024--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the High Court has notified Novacyt that the hearing of the case between … WebNOVACYT has raised a total of $37.8M in funding over 7 rounds. Their latest funding was raised on May 30, 2024 from a Post-IPO Debt round. NOVACYT is registered under the ticker LSE:NCYT . NOVACYT is funded by 4 investors. Kreos Capital and YA Global Master SPV are the most recent investors. NOVACYT has acquired 4 organizations. WebNovacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, … false or wrong